EMERGENT BIOSOLUTIONS INC. Treasury Stock, Value
EMERGENT BIOSOLUTIONS INC. (EBS) had Treasury Stock, Value of $227.70 million as of 2023-06-30, per its 10-Q filed 2023-08-09.
Discontinued › Balance Sheet › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:TreasuryStockValue · last filed 2023-12-11
- 2023-06-30: Treasury Stock, Value $227.70M.
- 2023-03-31: Treasury Stock, Value $227.70M.
- 2022-12-31: Treasury Stock, Value $227.70M.
- 2022-09-30: Treasury Stock, Value $227.70M.
| Period end | Treasury Stock, Value | Treasury Stock, Value as first filed |
|---|---|---|
| 2023-06-30 | $227.70M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $227.70M 10-Q · filed 2023-05-10 | |
| 2022-12-31 | $227.70M 10-K/A · filed 2023-12-11 | |
| 2022-09-30 | $227.70M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $227.70M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $204.40M 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $152.20M 10-K/A · filed 2023-12-11 | |
| 2021-09-30 | $39.60M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $39.60M 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $39.60M 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $39.60M 10-K · filed 2022-02-25 | |
| 2020-09-30 | $39.60M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $39.60M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $39.60M 10-Q · filed 2020-05-01 | |
| 2019-12-31 | $39.60M 10-K · filed 2021-02-19 | |
| 2019-09-30 | $39.70M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $39.70M 10-Q · filed 2019-08-02 | |
| 2019-03-31 | $39.60M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $39.60M 10-K · filed 2020-02-25 | |
| 2018-09-30 | $39.64M 10-Q · filed 2018-11-02 | |
| 2018-06-30 | $39.64M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $39.64M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $39.50M 10-K · filed 2019-02-22 | $39.50M 10-K · filed 2018-02-23 |
| 2017-09-30 | $6.50M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $6.50M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $6.50M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $6.42M 10-K · filed 2018-02-23 | |
| 2016-09-30 | $6.42M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $6.42M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $6.42M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $6.42M 10-K · filed 2017-02-28 | |
| 2015-09-30 | $6.32M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $6.32M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $6.32M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $6.32M 10-K · filed 2016-02-29 | |
| 2014-09-30 | $6.12M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $6.12M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $6.12M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $6.12M 10-K · filed 2015-03-09 | |
| 2013-09-30 | $5.91M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $5.91M 10-Q · filed 2013-08-06 | |
| 2013-03-31 | $5.91M 10-Q · filed 2013-05-03 | |
| 2012-12-31 | $5.91M 10-K · filed 2014-03-10 | |
| 2012-09-30 | $1.46M 10-Q · filed 2012-11-01 | |
| 2011-12-31 | $0.00 10-K · filed 2013-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |